Delay on inhaled insulin – a case of FDA “ooops”??
Roches‘s Actemra (RA treatment) approved by FDA – The Food and Drug Administration cleared the medicine, Actemra, in adults with moderate to severe rheumatoid arthritis, the Swiss drugmaker said today in a statement released by its South San Francisco, California-based Genentech unit. The FDA delayed approval in 2008 after the drug was backed by the agency’s outside advisers…more
All that hubbub from the story about how well anti-depressants really work: this is a pretty telling paragraph from the NY Times – That story begins to take shape when you consider what the new study actually said: Antidepressants do work for very severely depressed people, as well as for those whose mild depression is chronic. However, the researchers found, the pills don’t work for people who aren’t really depressed — people with short-term, minor depression whose problems tend to get better on their own. For many of them, it’s often been observed, merely participating in a drug trial (with its accompanying conversation, education and emphasis on self-care) can be anti-depressant enough…more
Curriculum Design. When it’s time to bring in some outside resources for designing curriculum (new hire, leadership, management development, etc.) we’ve got the suppliers you need. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
JUST FOR FUN
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply